Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News


Facebook Twitter LinkedIn Email Comments
Boston-based life sciences startup PhotOral has licensed patented technology from Forsyth Institute of Cambridge, Mass., to develop an intraoral device that uses blue light for targeting and obliterating potentially harmful dental plaque microorganisms. The agreement enables PhotOral to commercialize Forsyth’s photomedicine portfolio, which addresses the $7 billion oral care market. Stamatis Astra, PhotOral’s founder and CEO, is raising funds to support prototype production, clinical trials and marketing operations. The company’s goal is to have its first intraoral light cleaning device available by late this year. The Harvard University-affiliated Forsyth Institute, a nonprofit research organization focused on oral, craniofacial and related biomedical sciences, will conduct PhotOral’s clinical trials.

Feb 2012
Americasantimicrobial methodsBiophotonicsblue light technology for dental plaqueBusinessdental plaque microorganismsForsyth InstituteHarvard Universityintraoral deviceintraoral light cleaningMassachusettsMax GoodsonNikos Soukosperiodontal pathogensPhotOralphototherapyRapidScanStamatis Astra

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.